Nuvation Bio Statistics Share Statistics Nuvation Bio has 339.26M
shares outstanding. The number of shares has increased by 1.64%
in one year.
Shares Outstanding 339.26M Shares Change (YoY) 1.64% Shares Change (QoQ) 0.47% Owned by Institutions (%) 61.23% Shares Floating 228.13M Failed to Deliver (FTD) Shares 650 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 71.29M, so 21.05% of the outstanding
shares have been sold short.
Short Interest 71.29M Short % of Shares Out 21.05% Short % of Float 29.46% Short Ratio (days to cover) 11.78
Valuation Ratios The PE ratio is -1.26 and the forward
PE ratio is -3.89.
Nuvation Bio's PEG ratio is
0.
PE Ratio -1.26 Forward PE -3.89 PS Ratio 90.81 Forward PS 6.3 PB Ratio 1.54 P/FCF Ratio -5.48 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Nuvation Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.04,
with a Debt / Equity ratio of 0.02.
Current Ratio 9.04 Quick Ratio 9.04 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.07 Interest Coverage -1737.91
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $28.84K Profits Per Employee $-2.08M Employee Count 273 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -20.92% in the
last 52 weeks. The beta is 1.35, so Nuvation Bio's
price volatility has been higher than the market average.
Beta 1.35 52-Week Price Change -20.92% 50-Day Moving Average 2.21 200-Day Moving Average 2.31 Relative Strength Index (RSI) 50.01 Average Volume (20 Days) 6,072,975
Income Statement In the last 12 months, Nuvation Bio had revenue of 7.87M
and earned -567.94M
in profits. Earnings per share was -2.11.
Revenue 7.87M Gross Profit 795K Operating Income -592.63M Net Income -567.94M EBITDA -566.91M EBIT -567.6M Earnings Per Share (EPS) -2.11
Full Income Statement Balance Sheet The company has 35.72M in cash and 8.91M in
debt, giving a net cash position of 26.81M.
Cash & Cash Equivalents 35.72M Total Debt 8.91M Net Cash 26.81M Retained Earnings -910.74M Total Assets 647.23M Working Capital 556.85M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -130.41M
and capital expenditures -162K, giving a free cash flow of -130.57M.
Operating Cash Flow -130.41M Capital Expenditures -162K Free Cash Flow -130.57M FCF Per Share -0.49
Full Cash Flow Statement Margins Gross margin is 10.1%, with operating and profit margins of -7527.33% and -7213.76%.
Gross Margin 10.1% Operating Margin -7527.33% Pretax Margin -7213.76% Profit Margin -7213.76% EBITDA Margin -7200.75% EBIT Margin -7527.33% FCF Margin -1658.52%
